Projects per year
Fingerprint
Dive into the research topics where Thomas Matthew Habermann is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
Eastern Cooperative Oncology Group
Habermann, T. M., Hahn, R. & Edmonson, J.
12/31/89 → 2/28/14
Project: Research project
Research output
-
Hiding in (not so) plain sight: Spontaneous tumor Lysis syndrome due to intravascular large B cell lymphoma
Ho, M., Zanwar, S., Duggan, P., Carr, R., Habermann, T., Navin, P. J., Salama, M. E. & Parikh, S. A., Jan 1 2022, In: American journal of hematology. 97, 1, p. 151-159 9 p.Research output: Contribution to journal › Article › peer-review
-
Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412
Nowakowski, G. S., Hong, F., Scott, D. W., Macon, W. R., King, R. L., Habermann, T. M., Wagner-Johnston, N., Casulo, C., Wade, J. L., Nagargoje, G. G., Reynolds, C. M., Cohen, J. B., Khan, N., Amengual, J. E., Richards, K. L., Little, R. F., Leonard, J. P., Friedberg, J. W., Kostakoglu, L., Kahl, B. S. & 1 others, , Apr 20 2021, In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 39, 12, p. 1329-1338 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era
Boddicker, N. J., Larson, M. C., Castellino, A., Herrmann, J., Inwards, D. J., Thanarajasingam, G., Maurer, M. J., Allmer, C., Witzig, T. E., Nowakowski, G. S., Habermann, T. M., Villarraga, H. R., Slager, S. L., Cerhan, J. R. & Thompson, C. A., Aug 1 2021, In: American journal of hematology. 96, 8, p. 979-988 10 p.Research output: Contribution to journal › Article › peer-review
-
Aspirin and other nonsteroidal anti-inflammatory drugs, statins and risk of non-Hodgkin lymphoma
Liebow, M., Larson, M. C., Thompson, C. A., Nowakowski, G. S., Call, T. G., Macon, W. R., Kay, N. E., Habermann, T. M., Slager, S. L. & Cerhan, J. R., Aug 1 2021, In: International Journal of Cancer. 149, 3, p. 535-545 11 p.Research output: Contribution to journal › Article › peer-review
-
Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia
Abeykoon, J. P., Zanwar, S., Ansell, S. M., Muchtar, E., He, R., Greipp, P. T., King, R. L., Ailawadhi, S., Paludo, J., Larsen, J. T., Habermann, T. M., Inwards, D., Go, R. S., Thanarajasingam, G., Buadi, F., Dispenzieri, A., Thompson, C. A., Witzig, T. E., Lacy, M., Gonsalves, W. & 12 others, , Aug 1 2021, In: American journal of hematology. 96, 8, p. 945-953 9 p.Research output: Contribution to journal › Article › peer-review